In the present study, we show that even when treatment begins 24 h p.i. a single interruption and virus challenge was as sufficient as multiple interruptions plus viral challenges in reducing the efficacy of PMPA, instead results in persistent SIV antibody responses and long-term CD8-cell mediated suppression of virus infection. This evidence concerns the gene CD8A and viral infectious disease.